Agreed, not much content at all there. Nothing new. Seemingly pointless interview. However, I still believe this company has the products and the technology, and will be a medium to long game rather than a pump and dump type fast money biotech.
Company update, page-3
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
66.0¢ |
Change
-0.005(0.75%) |
Mkt cap ! $138.3M | |||
| Open | High | Low | Value | Volume |
| 67.5¢ | 76.5¢ | 64.5¢ | $2.707M | 3.773M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 65.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 70.0¢ | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| OCC (ASX) Chart |